GK PHARMA ApS: Financial statements 2017
CVR: 81267316
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
GK PHARMA ApS (CVR 81267316) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 8,828,873 and a net result of DKK 435,833 compared with DKK 113,357 the year before. That is an increase of 18% compared with the year before. The profit margin was 4.9%. Equity in the 2017 report amounted to DKK 200,000. The solvency ratio was 7.5%.
- Revenue
- DKK 8,828,873
- Gross Profit
- DKK 3,292,533
- Profit/Loss
- DKK 435,833
- Equity
- DKK 200,000
- Total Assets
- DKK 2,653,937
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 8.8 mio. | 3.3 mio. | 436 t. | 200 t. | - |
| 2016 | 7.5 mio. | 2.7 mio. | 113 t. | -236 t. | - |
| 2015 | 8.4 mio. | 3.5 mio. | 127 t. | -349 t. | - |
| 2014 | 9.3 mio. | 2.2 mio. | -790 t. | -476 t. | - |
| 2013 | 7.7 mio. | 2.5 mio. | 56 t. | 314 t. | - |
Official annual report
Keep an eye on GK PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
GK PHARMA ApS has published its annual report for 2016. Revenue came to DKK 7,480,198, and the net result was DKK 113,357.
As of March 6, 2017, Klaus Groth has joined the board of directors of GK PHARMA ApS.
As of March 6, 2017, Klaus Groth is registered as adm. dir. of GK PHARMA ApS.
As of January 1, 2017, Lars Skov Ibsen has left the board of directors of GK PHARMA ApS.
As of January 1, 2017, Lars Skov Ibsen has stepped down as adm. dir. of GK PHARMA ApS.
About GK PHARMA ApS
GK PHARMA ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 1977. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Klaus Groth. The board consists of Dorthe Groth (chair) and Klaus Groth. The company is owned by Salvefabrikken ApS. The company has 10 employees (2018). In 2025, the company reported a gross profit of DKK 5,931,212 and a net result of DKK 2,646,889 compared with DKK 954,244 the year before. Equity in the 2025 report amounted to DKK 4,029,041.